256 related articles for article (PubMed ID: 28600340)
41. Ethics in prevention science involving genetic testing.
Fisher CB; Harrington McCarthy EL
Prev Sci; 2013 Jun; 14(3):310-8. PubMed ID: 23354905
[TBL] [Abstract][Full Text] [Related]
42. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
[TBL] [Abstract][Full Text] [Related]
43. The ethics of genetic screening: the first report of the Nuffield Council on Bioethics: another personal view.
Shapiro D
J Med Ethics; 1994 Sep; 20(3):185-7. PubMed ID: 7996566
[No Abstract] [Full Text] [Related]
44. Ethical issues and policy analysis for genetic testing: Huntington's disease as a paradigm for diseases with a late onset.
Lilani A
Hum Reprod Genet Ethics; 2005; 11(2):28-34. PubMed ID: 16270448
[TBL] [Abstract][Full Text] [Related]
45. Preimplantation genetic diagnosis: technological promise and ethical perils.
Klipstein S
Fertil Steril; 2005 May; 83(5):1347-53. PubMed ID: 15866568
[TBL] [Abstract][Full Text] [Related]
46. Improving access to genetic testing for adults with intellectual disability: A literature review and lessons from a quality improvement project in East London.
Adlington K; Smith J; Crabtree J; Win S; Rennie J; Khodatars K; Rosser E; Hall I
Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):566-575. PubMed ID: 31077569
[TBL] [Abstract][Full Text] [Related]
47. Clinical Medical Ethics: Its History and Contributions to American Medicine.
Siegler M
J Clin Ethics; 2019; 30(1):17-26. PubMed ID: 30896440
[TBL] [Abstract][Full Text] [Related]
48. Naming and framing in genomic testing.
Bunnik EM; Schermer MH; Janssens AC
Trends Mol Med; 2014 Feb; 20(2):63-5. PubMed ID: 24485561
[TBL] [Abstract][Full Text] [Related]
49. Ethical considerations surrounding germline next-generation sequencing of children with cancer.
Johnson LM; Hamilton KV; Valdez JM; Knapp E; Baker JN; Nichols KE
Expert Rev Mol Diagn; 2017 May; 17(5):523-534. PubMed ID: 28399664
[TBL] [Abstract][Full Text] [Related]
50. Genetic testing for renal diseases: medical and ethical considerations.
Marsick R; Limwongse C; Kodish E
Am J Kidney Dis; 1998 Dec; 32(6):934-45. PubMed ID: 9856508
[TBL] [Abstract][Full Text] [Related]
51. Introduction to Bioethics Special Supplement V: Ethical Issues in Genomic Testing of Children.
Lantos JD
Pediatrics; 2016 Jan; 137 Suppl 1():S1-2. PubMed ID: 26729697
[TBL] [Abstract][Full Text] [Related]
52. Ethical, social and legal implications of genetic testing in liver disease.
van Leeuwen DJ; Bernat JL
Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
[TBL] [Abstract][Full Text] [Related]
53. [Ethical and social issues associated with genomic medicine].
Barazzetti G; Kaufmann A; Benaroyo L
Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
[TBL] [Abstract][Full Text] [Related]
54. Genomics Education in the Era of Personal Genomics: Academic, Professional, and Public Considerations.
Whitley KV; Tueller JA; Weber KS
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991576
[TBL] [Abstract][Full Text] [Related]
55. From genetics to genomics: ethics, policy, and parental decision-making.
Wilfond B; Ross LF
J Pediatr Psychol; 2009 Jul; 34(6):639-47. PubMed ID: 18647793
[TBL] [Abstract][Full Text] [Related]
56. Ethical considerations for pharmacogenomic testing in pediatric clinical care and research.
Moran C; Thornburg CD; Barfield RC
Pharmacogenomics; 2011 Jun; 12(6):889-95. PubMed ID: 21692618
[TBL] [Abstract][Full Text] [Related]
57. Bioethical theory and practice in genetic screening for type 1 diabetes.
Gustafsson Stolt U; Ludvigsson J; Liss PE; Svensson T
Med Health Care Philos; 2003; 6(1):45-50. PubMed ID: 12710563
[TBL] [Abstract][Full Text] [Related]
58. The ethics of pharmacogenomics.
Neil D; Craigie J
Monash Bioeth Rev; 2004 Apr; 23(2):9-20. PubMed ID: 15810202
[TBL] [Abstract][Full Text] [Related]
59. A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion.
Furman CD; Earnshaw LA; Doukas DJ; Farrer LA; Friedland RP
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):590-5. PubMed ID: 24615498
[TBL] [Abstract][Full Text] [Related]
60. Ethical considerations of population screening for late-onset genetic disease.
Golden-Grant K; Merritt JL; Scott CR
Clin Genet; 2015 Dec; 88(6):589-92. PubMed ID: 25677830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
